Pictet Asset Management’s Tango Therapeutics TNGX Stock Holding History

Pictet Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Buy	+582,262	New	+$14.4M	0.02%	550

Other funds holding TNGX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Pictet Asset Management's TNGX Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 582,262 shares worth $18.3M. The stake represents 0.02% of the portfolio and ranks #550 among its holdings.

28 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Pictet Asset Management held 582,262 shares of Tango Therapeutics worth $18.3M as of Q2 2026.
Tango Therapeutics was a new Pictet Asset Management position in Q2 2026.
Tango Therapeutics made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #550 holding.
28 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.